Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Point Of Use Remove


July 2016
SuSaFrThWeTuMo
24232221201918

Public Company News

Business Press Releases

Point Of Use Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12094030
By IGDRASOL
Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.
12078760
By IGDRASOL
IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.
12062970
By IGDRASOL
IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.
12049153
By IGDRASOL
IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.

All Press Releases

By Pure Planet Waters
Pure Planet Waters bottleless water coolers are the smarter, healthier alternative to primitive bottled water coolers. Besides being cleaner, healthier and more cost effective there are additional benefits to going bottleless...
12094030
By IGDRASOL
Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.
12078760
By IGDRASOL
IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.
12062970
By IGDRASOL
IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.
12049153
By IGDRASOL
IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.
12044119
By IGDRASOL
Personalization of paclitaxel therapy by combination of next generation nanoparticle paclitaxel and point-of-care therapeutic drug monitoring and biomarker testing.
By Universal Sensors Ltd
Fera study with Universal Sensors technology shows results in under one hour.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share